Aarti Pharmalabs Limited Logo
  • Home
  • Company
    • About Us
    • Board of Directors
    • Sustainability
      • Overview
      • Health & Safety
      • Environment
      • Responsible Workforce
      • Ethics
      • Social Commitment
      • Responsible Procurement
      • Compliance
      • Sustainability Reports
    • Facilities
    • Quality
    • Accreditations
    • CSR
    • News
  • Products & Services
    • Overview
    • API
    • Intermediates
    • CDMO Services
    • Caffeine
    • Xanthine Derivatives
    • Acid & Allied
  • R&D
  • Investors
    • Overview
    • Disclosures
    • Financial Information
    • Corporate Governance
    • Shareholders Information
    • Code and Policies
    • Downloads
    • Annual Reports
  • Careers
    • Why APL
    • Job Openings
  • Contact
Aarti Pharmalabs Limited Logo
  • Home
  • Company
    • About Us
    • Board of Directors
    • Sustainability
      • Overview
      • Health & Safety
      • Environment
      • Responsible Workforce
      • Ethics
      • Social Commitment
      • Responsible Procurement
      • Compliance
      • Sustainability Reports
    • Facilities
    • Quality
    • Accreditations
    • CSR
  • Products & Services
    • API
    • Intermediates
    • CDMO Services
    • Caffeine
    • Xanthine Derivatives
    • Acid & Allied
  • R&D
  • Investors
    • Overview
    • Disclosures
    • Financial Information
    • Corporate Governance
    • Shareholders Information
    • Code and Policies
    • Downloads
    • Annual Reports
  • Careers
    • Why APL
    • Job Openings
  • Contact

Quarterly Results

  1. Home
  2. Investors
  3. Financial Information
  4. Quarterly Results
  • Financial Information
  • Quarterly Results
  • Presentation
  • Concalls
  • Financial Hightlights
  • Subsidiary Companies Balance Sheets
  • Press Releases
  • Memorandum and Articles of Association
  • Annual Return

Unaudited Financial Results quarter and half year ended September 30, 2025

Unaudited financial statements for the quarter ended 30 June, 2025

Audited financial results for the year Ended 31st March 2025

Audited Financial Statements for Quarter ended December 31, 2024

Audited Financial Statements for the quarter ended September 30,2024

Audited Financial Statements for the Quarter ended June 30, 2024

Audited Financial Statements for the quarter and year ended March 31, 2024

Audited Financial Statements for the quarter ended December 31,2023

Audited Financial Results for Q2 H1 FY24

Audited Financial Statements for the quarter ended June 30,2023

Audited Financial Statements for the Year ended March 31, 2023

Audited Financial Statements for the nine months ended December 31, 2022

Audited Financial Statements for the quarter and year ended March 31, 2022

Aarti Pharma Labs Logo

Aarti Pharmalabs Limited is a leading Indian manufacturer of Pharmaceuticals and
Nutraceuticals with a global footprint.

Follow us:

Quick Links
  • Home
  • API
  • Intermediates
  • CDMO Services
  • Caffeine
  • Xanthine Derivatives
  • Acid & Allied
  • Careers
  • Contact
Company
  • About Us
  • Board of Directors
  • R&D
  • Facilities
  • Quality
  • Accrediatations
  • Investors
  • News
Get in Touch

Aarti Pharmalabs Limited

CIN: L24100GJ2019PLC110964
2nd Floor, 204, Udyog Kshetra, Mulund - Goregaon Link Rd, Mulund (W), Mumbai, Maharashtra - 400 080.

Email

info@aartipharmalabs.com

Call

+91 22 6943 6100


Copyright © 2025 Aarti Pharmalabs Limited All Rights Reserved.

Designed and Developed by Claps and Whistles.